Pain treatment program gives patients new lives   Marsalis shares his expertise, love of jazz
     
McCoy heads epidemiology and public health   University AIDS researchers make breakthrough discovery
     
Pottery sale a sure-fire hit   Sunbeam's Dunlap speaks at new Storer Auditorium
     
UM/Sylvester holds regional forum   UM at Chicago broadcast museum
     
 

Pain treatment program gives patients new lives

Myer Schnitzer is busy these days enjoying and planning his new life after years of pain and disability. The 66-year-old Boca Raton, Florida, man injured his back in 1987 lifting an engine while working as an auto mechanic.

"I went through ten years of chronic back pain and suffering," relates Schnitzer. He underwent back surgery and traction with minimal relief. Schnitzer attempted to return to work at light duty, but a rear-end auto accident in 1990 undid even his minor improvements. The next seven years would see him in therapy, trying to find some way to rebuild his life.

"I attended numerous therapy programs, received a spinal cord stimulator implant, 26 epidural injections, nerve block injections, ten hospitalizations, and the maximum allowable narcotic drug therapy," says Schnitzer. "I wore a back brace 24 hours a day, and still nothing helped."

Schnitzer became dependent on the pain medications and spent most of his days in bed. He was unable to dress himself or even stand to take a shower. "My wife became my servant. My children were afraid to visit or even call me," says Schnitzer. "A simple sneeze sent me into such agony, I would go to bed for days."

Finally in the spring of 1997, desperate to regain a normal life, he investigated another back surgery. Instead, the surgeon recommended the University of Miami Comprehensive Pain and Rehabilitation Center (CPRC).

Located at South Shore Hospital on Miami Beach, the CPRC is one of the oldest and largest pain treatment programs in the world. Founded in 1974 as a program of the School of Medicine, the center was created specifically to treat people with chronic pain­especially of the back. The facility is famous for its success with people who have not responded to standard procedures or care. Many patients who had been told to live with their pain have returned to productive normal lives after care at the CPRC.

"When I was referred to the Comprehensive Pain and Rehabilitation Center, I was very skeptical and apprehensive," remembers Schnitzer. "I had been disappointed by every other program. But I had no alternative. I was literally at the end of my life physically, emotionally, and spiritually."

Schnitzer entered the CPRC in April with his medications, wearing a back brace and using a walker. Immediately a dedicated team of physicians, psychologists, nurses, therapists, and other professionals concentrated on a holistic approach to his pain, emphasizing kindness, caring, individualized goal-oriented therapy, activation, and return to maximum function.

This approach to pain and its cause was pioneered by the CPRC's founder and Medical Director, Hubert L. Rosomoff. "The source of much chronic pain," says Rosomoff, "is not injury to joints, nerves, or vertebrae but to the tissues surrounding them." Contrary to popular belief, Rosomoff declares that "Pinched nerves aren't the primary cause of pain. A high percentage of people with chronic back pain, for instance, have no neurologic abnormalities."

Rosomoff, professor and chairman emeritus of the Department of Neurological Surgery, says a vicious cycle develops. "Pain leads to sustained contraction of the muscles. This in turn prompts people to be less active for fear of increasing their pain, but inactivity merely leads to worse muscle contractures and more pain," says Rosomoff. "This is accompanied by stress, anxiety, and fear, which all become a part of the pain cycle."

Rosomoff's center believes in aggressive stretching, activation, and detoxification from pain medications. "Medications merely mask pain," says Rosomoff. "They do nothing to resolve the problem causing the pain. You can't fully participate in therapy while taking a lot of medications. Besides, they offer only temporary help. Eventually you must take higher and higher doses."

And what about Myer Schnitzer? After four weeks of treatment, he was discharged from the CPRC in May with complete resolution of his pain, depression, and medication dependence. Walking three miles a day and completely independent, he is now enjoying his family. He and his wife just returned from a week-long cruise to celebrate.

"My pain is gone, and I am living a full and rewarding life," says Schnitzer. "I am a human being again."

 
 

Marsalis shares his expertise, love of jazz

Wynton Marsalis, one of the world's top jazz and classical trumpeters, participated in a week-long residency at the School of Music as part of Festival Miami '97. A multiple Grammy Award winner, Marsalis is also known as one of the nation's most articulate and influential spokespersons for the arts.

One of the week's highlights included a lecture at the Maurice Gusman Concert Hall on September 24 that was free and open to the public. During the forum, he discussed his nationwide efforts to recognize the importance of music as an essential component in the education and enrichment of young and old alike.

During his residency, Marsalis held a number of master's classes with University of Miami and other local students. His residency culminated on Saturday, September 27, with a performance by the University Concert Jazz Band guest conducted by Marsalis and featuring works by Duke Ellington, Count Basie, and Marsalis himself. Tickets for the event were sold out weeks ahead of time, and the event was a crowd-pleasing spectacular.

Marsalis is widely credited with inspiring revitalization in jazz as an art form. Ten years ago, he started a jazz program at Lincoln Center that has since developed an international agenda with up to 150 events annually in 15 countries. Through his exhaustive efforts, Marsalis has garnered recognition for an older generation of jazz musicians, stimulated the development of jazz curricula in schools nationwide, and inspired an entire generation of young musicians.

 
 

McCoy to head Epidemiology and Public Health

Clyde B. McCoy, director of the University of Miami Comprehensive Drug Research Center and the Health Services Research Center, has been named chairman of the Department of Epidemiology and Public Health.

"Dr. McCoy has distinguished himself as one of this nation's preeminent scholars in epidemiology and public health, and we are proud to have him lead our program," said John G. Clarkson, senior vice president for medical affairs and dean of the School of Medicine.

With 25 years of service at the University, McCoy has become an internationally known researcher in community and population studies in oncology, HIV/AIDS, substance abuse, and health services, which are documented in more than 200 publications. His work in the early detection of breast cancer has become a national model. The University of Miami/Sylvester Comprehensive Cancer Center mobile mammography vans, anchored by the Jackson Breast Health Center, have become hallmarks of early breast cancer detection for thousands of indigent women living in Dade County.

Also a professor of epidemiology and public health, McCoy is a leader in the field of substance abuse and HIV, distinguishing the University of Miami as one of the top drug research programs in the United States. Last year, the Comprehensive Drug Research Center was one of two sites awarded a national research center to study how health care services can be more accessible and effective for substance abusers.

 
 

University AIDS researchers make breakthrough discovery

A triple drug combination of protease inhibitor, AZT, and 3TC cuts the risk of AIDS-related infections, cancers, and deaths nearly in half, according to research recently published by University of Miami specialists and other national colleagues in the New England Journal of Medicine.

"This is the first time a three-drug combination therapy regimen, which includes a protease inhibitor, has been shown to have clinical benefits," says Margaret A. Fischl, professor of medicine, director of the University's AIDS Clinical Research Unit, and a senior author of the study. "This now defines the standard of care."

This triple-drug combination, one a potent protease inhibitor (indinavir), was recommended as a "preferred" treatment for well-established HIV infection in the spring 1997 patient care guidelines from the Department of Health and Human Services' Panel on Clinical Practices for Treatment of HIV Infection. This new therapy comes exactly ten years after identifying the first successful AIDS drug, AZT, of which Fischl was a primary researcher.

The study, conducted by the National Institutes of Health's AIDS Clinical Trial Group, provides the first clinical proof that triple drug therapy is superior to the former two-drug therapy of AZT and 3TC.

Specific findings showed a 50 percent reduction in progression of HIV status to AIDS/AIDS-related infections (6 percent, compared to 11 percent on the AZT/3TC) and a 57 percent reduction in deaths (1.4 percent, compared to 3.1 percent on the AZT/3TC). A significant decline in viral load was also realized, in addition to numerous patients experiencing an undetectable level of HIV in the blood after the one-year study.

Diversity of the patient base was a particularly important aspect of the study; 28 percent of participants were African-American, 19 percent were Hispanic, and 17 percent were women. The entire study included 1,156 patients, nearly 50 at the University of Miami.

 
 

Pottery sale a sure-fire hit

Come one, come all! Be sure not to miss the 23rd annual pottery sale, one of the University's best-kept secrets. Hosted by the art department's Potters' Guild, headed by Christine Federighi, professor of ceramics, the sale will feature unique pieces by undergraduates, graduate students, and faculty.

This year's event will be held on the Whitten University Center Patio on Thursday, November 20, from 9:30 a.m. to 4 p.m., offering many attractive items at reasonable prices.

Proceeds from the sale will go to the Visiting Artist Fund. In the past, the University has hosted many nationally known artists such as: Ralph Bacerra, Edward Eberle, Chris Guston, Judy Moonelis, Stephen de Stabler, Steven Hill, Richard Notkin, Bill Daley, Paul Dresang, and Andrea Gill.

Come early and shop for the holidays!

 
 

Sunbeam's Dunlap speaks at new Storer Auditorium

Albert J. Dunlap, chairman and chief executive officer of the Sunbeam Corporation, spoke on September 11 in the School of Business Administration's new 300-seat Storer Auditorium. The first scheduled speaker of the Cobb Leadership Lecture Series presented by Ambassador and Mrs. Charles E. Cobb, Jr., Dunlap addressed students, faculty, and alumni of the school on his secrets to success.

Known for his slash-and-burn corporate makeovers, Dunlap has become one of the most controversial figures on Wall Street. He cut 11,000 jobs in his turnaround of ailing Scott Paper Corporation, and its stocks rose 200 percent under his watch. A former marine and best-selling author of Mean Business, Dunlap also engineered the sale of the company to Kimberly-Clarke (now Kimberly-Scott) for $9 billion-all in just 19 months.

Wasting little time in his new position at Sunbeam, Dunlap claims to have cut 6,000 jobs at the Delray Beach, Florida-based small appliance maker. He also noted that the company's stock has tripled in just over a year since he took the helm, with market capitalization increasing by more than $2 billion.

The revamping efforts at Sunbeam have been met with criticism, particularly the job cuts. But in his speech, Dunlap pointed to the internal changes he has made at Sunbeam: creating new advertising, increasing the pace of new product development, globalizing the brand, and opening new channels of distribution.

The Cobb Leadership Lecture Series was endowed by the Cobb Family Foundation. The purpose of the series is to bring to campus the nation's leading experts on various styles of leadership and to foster a greater understanding of the importance of strong leadership in the business world.

 

UM/Sylvester holds regional forum

The University of Miami/Sylvester Comprehensive Cancer Center presented "Increasing Participation of Minorities and Older Americans in Clinical Research" on September 17, 1997, at the Biltmore Hotel.

Among the presenters was Edward Trapido, professor and associate director for cancer prevention and control at the Sylvester Comprehensive Cancer Center, recently appointed associate director for education of the Southeastern Cancer Genetics Research Consortium. Also recently elected chair of the advisory committee to the board of directors of the North American Association of Central Cancer Registries, Trapido spoke on Florida's highest crude incidence rate of cancer of any state. He pointed out that one case will be diagnosed in Florida every 5-1/4 minutes.

According to Trapido, with one out of every 14 cases of cancer in the nation diagnosed among Florida residents, there are considerable opportunities for enrollment of African-Americans, Hispanics, and older Americans in prevention and therapeutic trials. Furthermore, although the site distribution of cancer among these groups generally looks similar, Trapido explained the differences.

Florida residents over age 60 have proportionately more lung and bladder cancers diagnosed than do Hispanics or African-Americans, while Hispanics have proportionately more non-Hodgkin's lymphoma than the other groups. African-Americans have proportionately more prostate and cervical cancers, and fewer colorectal cancers, Trapido further noted.

Presenters from UM/Sylvester, the University of South Florida's H. Lee Moffitt Cancer Center, and community hospitals throughout South Florida provided an overview of the importance of participation by Hispanics, African-Americans, and older Americans in clinical trials.

Also discussed were the barriers involved with recruitment of these populations as they addressed financial, ethical, and psychosocial considerations. Speakers presented successful strategies for overcoming these barriers, and they helped participants develop goals and plans to increase recruitment of these populations into clinical trials.

The National Cancer Institute has committed to increasing participation of minorities in clinical trials as one of its national priorities. UM/Sylvester received one of only a few NCI-sponsored grants nationwide to hold this regional forum.

 
 

UM at Chicago broadcast museum

Is the Media Mugging Chicago? That was the topic of the night when Professor Joseph Angotti (right), founder of the Consortium for Local Television Suveys and holder of the Communication Studies Chair in the School of Communication, addressed a gathering of UM alumni and communication professionals at the Museum of Broadcast Communications at the Chicago Cultural Center last month. Angotti discussed the results of his research on the disappointing level of crime news on local television, and its effect on viewership. President and Mrs. Edward T. Foote II greeted the Chicago area alumni and updated them on the recent successes of the University.

 

Home Page Links

Veritasonline Home Page | University of Miami Home Page